Herpes Simplex Viruses (HSV) infect human and murine dendritic cells (DCs) and interfere with their immunostimulatory functions in culture. HSV-2 infection increases human immunodeficiency virus (HIV) spread in patients and DCs also promote HIV infection. We have studied these topics in rhesus macaque monocyte-derived DCs (moDCs), to set the stage for future studies of these issues in animals. We provide the first evidence that macaque DCs become infected by HSV-2. Structural viral proteins (ICP5, gD, envelope) were detected in the cell periphery and a functional protein (ICP8) was predominantly found in the nucleus after infection. Infectious HSV-2 induced apoptotic death, decreased expression of HLA-DR, CD40, CD80, CD83, and CD86, and increased release of IL-6, TNF-, MIP-1 (CCL3), and RANTES (CCL5), but not IL-12 or IFN-by macaque DCs. This coincided with HSV-2-infected DCs stimulating weak T cell responses, including impaired SIV-specific responses. Comparable HSV-2 protein expression, DC apoptosis, as well as membrane immunophenotype and functional modifications were observed in HSV-2-exposed human moDCs. Such HSV-2-induced modifications of macaque and human DCs could augment DC-driven immunodeficiency virus infection. This work affords the basis for future macaque studies to explore how HSV-2 impacts the efficacy of strategies being developed to prevent HIV transmission.
Introduction
Dendritic cells (DCs) are involved in innate and adaptive immunity. [1] [2] [3] [4] [5] DCs survey for pathogens to which they respond innately while also processing pathogens and presenting antigenic determinants to induce adaptive immune responses. DCs need to be activated or matured to stimulate potent adaptive immunity. 6 Maturation involves the up-regulation of molecules on the DC surface and secretion of cytokines and chemokines that encourage the DC-T cell interactions needed to elicit strong immunity. Many pathogens trigger these pathways, modifying DC functions to encourage effective immune activation and clearance of infection. [7] [8] [9] [10] Yet, other pathogens like immunodeficiency viruses (human, HIV and simian, SIV) [11] [12] [13] [14] [15] and herpes simplex viruses (HSV) [16] [17] [18] exploit DC biology to facilitate infection and elicit immune responses incapable of preventing or eradicating infection. Moreover, there is a strong correlation between genital HSV (HSV-2) infection and the probability of acquiring HIV. 19 Understanding how this might be orchestrated at the DC level is central to developing strategies to prevent DC-driven HIV spread.
12
Primary HSV-2 infection, occurring at the mucosal surfaces, is typically followed by the establishment of latency in the sacral root ganglia. 20 Neutralizing Abs and antiviral CD4 + and CD8 + T cells are induced, 20 which ultimately restrict virus replication at local sites to resolve (primary and reactivated) lesions. 21, 22 DCs likely play a key role by orchestrating responses to HSV, 21, [23] [24] [25] although low-level productive infection of DCs might also contribute to virus spread. 18 HSV infection of human monocyte-derived DCs (moDCs) is cytopathic 23, 26, 27 and results in the down-modulation of several surface markers involved in the activation of T cells. [16] [17] [18] While this would result in mediocre anti-HSV immunity allowing the establishment of HSV infection (but not preventing
For personal use only. on April 14, 2017. by guest www.bloodjournal.org From infection), it must be sufficient to clear virus upon reactivation. 24, 25 Herpetic lesions also comprise activated leukocyte infiltrates and enable direct blood contact, providing mechanisms for increased HIV spread. It is possible that HSV-2 infection of immature DCs additionally alters innate DC responses and compromises the ability of DCs to elicit potent adaptive responses to other pathogens thereby further exacerbating HIV infection.
The initial step towards dissecting this biology in a relevant animal model was to validate HSV-2 infection of macaque DCs. We provide the first proof that immature macaque moDCs can be infected by HSV-2. We observed DC apoptosis upon exposure to infectious HSV-2 as well as reduced immunostimulatory functions in HSV-2-infected DCs. Notably, HSV-2-infected DCs stimulated weaker SIV-specific T cell responses.
These data will enable future studies in the macaque to explore how HSV-2 infection affects DC-driven HIV transmission and if the presence of co-infections, like HSV-2, influence the efficacy of preventative or therapeutic approaches.
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Materials and Methods

Animals
Adult rhesus macaques (Macaca mulatta) were bred and housed at the Tulane National Primate Research Center (TNPRC; Covington, LA). At the commencement of these studies all naïve animals tested negative by PCR for simian type D retroviruses, simian T cell leukemia virus, and SIV. Healthy SHIV162P-infected macaques (infected ~6 years ago) were used as a source of virus-primed T cells for SIV-specific immune assays. 15 Protocols were reviewed and approved by the Institutional Animal Protocols Care and Use Committee of the TNPRC. Animal care procedures were in compliance with the regulations detailed under the animal welfare act, and in the "Guide for the care and use of laboratory animals".
Generation of immature moDCs
Peripheral blood mononuclear cells were isolated from heparinized macaque blood or human leukopacks (New York Blood Center) using Ficoll-Hypaque density gradient centrifugation (Amersham Pharmacia Biotech AB, Uppsala, Sweden). CD14 + monocytes were isolated using the non-human or human primate CD14 MACS system (Miltenyi Biotech, Auburn, CA) and moDCs generated by culturing these cells in 100U/ml recombinant human IL-4 (R&D Systems, Minneapolis, MN) and 1000U/ml recombinant human GM-CSF (Berlex Laboratories, Montville, NJ). 28,29 After 6-7d, immature DCs were collected, an aliquot taken for flow cytometry and the remainder used for HSV-2 infections. DC phenotype was assayed using FITC-conjugated anti-HLA-DR (clone L243, Becton Dickinson, BD, Biosciences, San Jose, CA) in combination with PE- Culture medium (R1) was RPMI 1640 (Cellgro; Fisher Scientific, Springfield, NJ) containing 2mM L-glutamine (GIBCO-BRL Life Technologies, Grand Island, NY), 10mM HEPES (GIBCO-BRL Life Technologies), 50µM 2-mercaptoethanol (Sigma Chemical Company, St. Louis, MO), penicillin (100 U/ml) and streptomycin (100µg/ml) (GIBCO-BRL Life Technologies), and 1% heparinized human plasma.
HSV-2 infection
Viral stocks were propagated in Vero cells (American Type Culture Collection, ATCC, Manassas, VA), titered by plaque formation on Vero cells, 30 and aliquots stored at -80ºC.
Immature moDCs were exposed to HSV-2 (strain G; ATCC) at 1 or 5 plaque-forming units (pfu) per cell for 1h at 37°C. Controls were set up along side where DCs were exposed to the medium in which the viral stocks were grown (DMEM 2% FBS).
Typically, 10 6 cells were added to eppendorf tubes (pre-coated with RPMI 10% FCS on ice for 5-10min) in a final volume of 100µl of R1 containing 1-5pfu of HSV-2/cell. After incubation, cells were washed five times with 500µl of cold R1 (3min, 3000 RPM) to remove unbound virus. Cells were recounted, resuspended in medium with 1000U/ml GM-CSF and 100U/ml IL-4 and plated at 0. Billerica, MA). The plate was read on a Luminex 100 Instrument (Luminex Corporation, Austin, TX). Data were analyzed using the STarStation software (Applied Cytometry System, Inc., Sacramento, CA). IL-12 levels were also monitored in the DC supernatants using the macaque-reactive IL-12 (p70 and p40) ELISA (BioSource International, Inc., Camarillo, CA) and IFN-levels were measured using the monkey-cross reactive Human IFN-ELISA Kit (BioSource), according to the manufacturer's instructions.
SIV-specific assay
Blood from healthy, SHIV162P-infected animals was used as a source of SIV-primed T 
Results
HSV-2 proteins are expressed by infected immature macaque DCs
HSV-2-exposed immature macaque DCs were analyzed immediately or after re-culture for the expression of viral proteins ( Figure 1 ). Within 4h of re-culture, we observed cytoplasmic expression of the major HSV-2 capsid protein (ICP5) and gD as well as the products of the env gene ( Figure 1A ). The HSV-2 single-strand DNA binding protein, ICP8, was detected after overnight re-culture of HSV-2-exposed DCs ( Figure 1A ) but not earlier (not shown). ICP8 was predominantly expressed in a nuclear pattern ( Figure 1A and B), with points of more intense staining sometimes at the periphery of the nucleus.
No HSV-2 proteins were detected immediately following the virus pulse (not shown) and all IgG controls were negative ( Figure 1A , lower row).
Monitoring ICP8 expression as a stringent measure of infection, flow cytometry was used to quantify the numbers of ICP8 + DCs ( Figure 1C and D). Unlike mediumtreated DCs (<1% ICP8 + ), ICP8 expression was evident after infection and this increased with time ( Figure 1C ). This result was confirmed in 15 experiments using cells from 7 different animals ( Figure 1D ), averaging 4.36% ICP8 + (1.43-8.11%) after 4h and 14.69% ICP8 + (6.37-34.5%) after overnight re-culture. HSV-2-exposed human moDCs showed similar ICP8 expression ( Figure 1D ), typically in a nuclear localization (not shown).
Thus, exposure of immature macaque DCs to HSV-2 resulted in the increased expression of HSV-2 proteins over time, indicative of viral infection not uptake of virus particles.
HSV-2 infection of macaque DCs is cytotoxic
For personal use only. on April 14, 2017. by guest www.bloodjournal.org From HSV infection leads to apoptosis of DCs from other species. 26, 27, 35 Microscopic examination of HSV-2-infected macaque DCs suggested that these cells were unhealthy.
FACS data revealed that a large proportion of the HSV-2-exposed DCs, especially the ICP8 + cells, were smaller in size, based on their forward scatter profiles (e.g., Figure 1C ), further indicative of poor cell health. There was a considerable reduction in the numbers of trypan blue-negative viable cells recovered after overnight culture (48.6% uninfected versus 22.13% infected; Figure 2A ).
Cells were also stained with Annexin V/PI to identify apoptotic and necrotic cells.
Increases in the percentages of early apoptotic (Annexin V + PI -; 58.9% versus 9.49%) as well as late apoptotic/necrotic (Annexin V + PI + ; 28.6% versus 10.1%) cells were evident in the HSV-2-infected DCs (versus medium-treated controls; Figure 2B ). There was a slight increase in the percentage of apoptotic cells after 4h of re-culture, but this was greater after overnight incubation of HSV-2-infected macaque DCs (average of 45.72% versus 16.66% in HSV-2-infected versus uninfected cells; Figure 2C ). The percentages of cells in late apoptosis/necrosis increased even further over time (average of 82.15% versus 30.61% in HSV-2-infected versus uninfected cells; Figure 2C ). This was due to infection, since exposure to the same amount of UV-inactivated HSV-2 did not induce DC death (similar to medium-exposed controls). This mirrors results for human DCs ( Figure 2C ).
Changes in macaque DC surface marker expression induced by HSV-2 infection
Initially, we observed that HLA-DR and CD86 expression were reduced in the HSV-2-infected macaque DCs after overnight re-culture, but not after 4h of re-culture ( Figure 3A For personal use only. on April 14, 2017. by guest www.bloodjournal.org From and B). More extensive examination revealed that HLA-DR, CD40, CD80, CD83, and CD86 were decreased on cells expressing the highest levels of ICP8 (defined as ICP8 + ; Figure 3C ). These markers were largely unaffected or even slightly elevated on ICP8 -cells within the infected macaque DC cultures (uninfected or low level infection), compared to the medium-cultured controls. Interestingly, cells from 3 animals infected with only 1pfu of HSV-2 per cell (average 1.66% ICP8 + ) exhibited increased levels of several of these surface markers on the ICP8 -cells, but the levels of costimulatory molecule expression were still lower in the ICP8 + fraction ( Figure 3C ). These cells were clearly far healthier than cells exposed to 5pfu of HSV-2 per cell (microscopic examination and FSC profile; not shown). We confirmed that the down-modulation of the costimulatory molecules requires infectious HSV-2, that exposure to UV-treated HSV-2 tended to increase the expression of these markers (like ICP8 -cells in the low-level infected cultures), and that these responses reflected those seen in human moDCs ( Figure   3D ).
Modulation of macaque DC cytokine/chemokine profiles upon HSV-2 infection
As a functional measure of DC activity after exposure to infectious HSV-2 we evaluated the production of certain soluble factors over time. Infectious (not UV-treated) HSV-2 induced IL-6, TNF-, MIP-1 (CCL3), and RANTES (CCL5) secretion by macaque DCs during the overnight re-culture ( Figure 4 ). UV-treated HSV-2 induced (at best) lowlevel IL-6, CCL3, and CCL5 release by macaque DCs. Some IL-6, TNF-, and CCL3
were detected within 4h of infection, with the TNF-response being maintained after overnight re-culture. Contrastingly, HSV-2 induced little IL-12 p40 secretion by macaque 
Decreased T cell stimulatory capacity of HSV-2-infected macaque DCs
Since HSV-2 infection modulated the expression of costimulatory molecules and soluble factors by macaque DCs, we investigated whether this influenced their ability to stimulate a MLR. 32 Because HSV-2 infection resulted in dramatic cell death after overnight re-culture, we tested the immunostimulatory activity of HSV-2-infected versus uninfected DCs after 4h of re-culture (when cells were still healthy; Figure 2 ).
Although the same numbers of viable DCs were compared, HSV-2-infected immature DCs stimulated considerably less T cell proliferation than medium-or UV-HSV-2-exposed DCs ( Figure 5 ). Representative responses induced by macaque versus Figure 5A ). Most assays were performed using fresh (unfixed) DCs ( Figure 5A and B) . Thus, the lower proliferative responses activated by infected DCs might simply have reflected the loss of DCs (and, hence, immunostimulatory activity) due to virus-induced DC death during the MLR cultures. Therefore, we compared PFA-fixed and unfixed HSV-2-infected and uninfected macaque DCs. The overall levels of T cell proliferation were reduced when the DCs were PFA-fixed (not shown), as would be expected since the fixed DCs could not mature further in culture (upon T cell contact). However, the difference between the magnitudes of the responses induced by HSV-2-infected and uninfected DCs persisted ( Figure 5C ).
Luminex analyses revealed consistently lower responses in MLRs stimulated by HSV-2-infected macaque ( Figure 6 ) and human (not shown) DCs. Although IL-2 levels were comparable after 5d, examination after 1d of culture confirmed that more IL-2 was produced earlier in the cultures stimulated by uninfected DCs, coinciding with greater T cell proliferation ( Figure 5 ). All other factors were highest in the 5d cultures (not shown) and the levels of factors released in cultures stimulated by HSV-2-infected DCs were consistently lower than those induced by uninfected DCs (Figure 6 ). Comparable patterns (of lower magnitude) were seen in the supernatants collected from the cultures set up with PFA-fixed DCs (not shown). Comparing medium-, UV-treated HSV-2-and live HSV-2-exposed DCs side-by-side, we verified that these decreased responses were dependent upon DC exposure to infectious HSV-2 (not shown).
HSV-2-infected immature macaque DCs induce poor SIV-specific responses
For personal use only. on April 14, 2017. by guest www.bloodjournal.org From To extend our examination of the impact of HSV-2 infection on DC functions and to begin to understand how HSV-2 might impact SIV infection, we measured the capacity of HSV-2-infected moDCs to stimulate SIV-specific T cells. We achieved this by using DCs and T cells from healthy infected macaques and chemically inactivated AT-2 SIV as the antigen. 15, 29, 32 Preliminary flow cytometric analyses using fluorescently labeled viruses produced by cultures of healthy uninfected DCs and T cells were not detected in the HSV-2-infected DC-T cell mixtures ( Figure 7D ). PHA-induced TNF-, CCL3, and CCL5 secretion was also lower in the HSV-2-infected DC-T cell cultures.
For
Discussion
Epidemiological studies demonstrated that HSV-2 increases the frequency of HIV-1 transmission by 2-4 fold. 19 Although mucosal epithelial cells (mainly keratinocytes) and sensory neurons are primary targets for HSV infection, 38-40 DCs can become infected by HSV and their function down-modulated as a result. 16, 17, 23, 35 In addition to herpetic lesions affording HIV direct access to the blood and the activated leukocytes recruited to the lesions, we hypothesize that HSV-2 infection of DCs compromises their innate and adaptive activities to further exacerbate HIV transmission. Exploring ways to use the macaque system to study the spread of HIV in the face of STDs, we provide the first evidence that HSV-2 infection of macaque DCs modifies their capacity to stimulate strong immunity, underscoring the potential for this animal model.
Similar to reports on murine 35 and human 18, 23, 27, 36 DCs along with the human data herein, immature macaque DCs can be infected by HSV-2 ( Figure 1) . Discrepancies between the kinetics of infection and protein expression in each system probably reflect differences in the DCs used (bone marrow-derived DCs versus moDCs versus Langerhans cells in different species), the virus isolates examined (HSV-1 versus HSV-2), the different assays employed to monitor infection, and the time points after infection when the cells were analyzed. However, the predominantly nuclear localization of ICP8 in infected macaque DCs agrees with the fact that the single-strand DNA binding protein ICP8 is important for HSV-2 replication, accumulating in replication complexes within the nuclei.
41,42
In all species, infectious HSV is cytotoxic and induces apoptosis of DCs ( Figure   2 ). 26, 27, 35, 36 Figure 5A) . 16, 23, 35, 36 This was evident at the level of T cell proliferation and the magnitudes of cytokine and chemokine responses in DC-T cell co-cultures. Decreased immunostimulatory activity was evident in macaque and human DCs within 4h of HSV-2 infection when membrane phenotypic changes were negligible but functional modifications were already apparent. This emphasizes the profound and rapid impact HSV-2 infection has on both macaque and human DCs. The most notable differences observed between human and macaque DCs were the kinetics of some of the cytokine responses and the lack of detectable CCL3 and CCL5 release by HSV-2-infected human DCs within the time frame examined. Importantly, however, DCs from both species manifested similarly impaired immunostimulatory function. Moreover, while the release of soluble factors was lower in HSV-2-infected (human and macaque) DC-T cell mixtures, there was no shift from Th1 to Th2 type responses. Therefore, although
For personal use only. on April 14, 2017. by guest www.bloodjournal.org From responses were less robust, Th1 responses would still be able to be induced by HSV-2-infected DCs to ultimately control infection. This parallels the delayed or sub-optimal responses described in the human system, which can be offset by uninfected DCs within an infected population cross-presenting HSV antigens. 23, 27, 45 Innate activation of DCs through TLR stimulation by HSV also likely contributes to controlling HSV infection. This represents the first report demonstrating the modified immune functions of HSV-2-infected macaque DCs, validating the similarities between macaques and humans, and that HSV-2 infection compromises the capacity of DCs to stimulate SIV-specific responses. Whether this influences how HIV/SIV modifies immature moDCs 12, 13, 47, 48 remains to be determined and can now be explored in vivo in the macaque system. Being able to model HSV-2 infection in macaques, we are studying the impact of HSV-2 infection on transmission and testing how HSV-2 alters the efficacy of microbicide or vaccine strategies in preventing HIV spread. Identifying approaches that function effectively in the face of other infections, especially those that down-modulate immune function will be critical in preventing the spread of HIV and other STDs. Cell-free supernatants were collected (after 4h or ON re-culture) from infected (5pfu/cell) versus uninfected (+ versus -) immature macaque moDC cultures. Cells from an additional 2 donors were also exposed to UV-treated HSV-2 (UV) and samples collected after overnight re-culture. The presence of cytokines and chemokines was measured using the 22-plex Luminex assay (Upstate). The mean concentration of each cytokine/chemokine (mean pg/ml ± SEM) is shown from 3 to 17 experiments after 4h reculture, from 15 to 21 experiments after ON re-culture for uninfected versus infected DCs, and from 2 donors exposed to UV-treated HSV-2. Values for the CXCL8 responses from the 2 experiments comparing cells exposed to medium versus HSV-2 (live or UVtreated) have been set at the 5000pg/ml maximal value since the levels were out of range in the Luminex assay (with comparable MFIs for the differently treated cells). As a result, there are no error bars shown for the UV-treated HSV-2 cell control. PHA-induced TNF-, CCL3, and CCL5 responses were also lower in cultures stimulated with HSV-2-infected DCs (16.19 versus 80.66, 18.78 
